Telemedicine technologies are rapidly being integrated into infectious diseases programs with the aim of increasing access to infectious diseases specialty care for isolated populations and reducing costs. We summarize the utility and effectiveness of telemedicine in the evaluation and treatment of infectious diseases patients. The use of telemedicine in the management of acute infectious diseases, chronic hepatitis C, human immunodeficiency virus, and active pulmonary tuberculosis is considered. We recapitulate and evaluate the advantages of telemedicine described in other studies, present challenges to adopting telemedicine, and identify future opportunities for the use of telemedicine within the realm of clinical infectious diseases.
Telemedicine refers to the use of telecommunication and information technologies with the goal of providing clinical healthcare to distant or isolated individuals. The utilization of this technology can eliminate distance barriers and improve medical services access that otherwise would not be available. Telemedicine technologies are increasingly prevalent tools used to deliver healthcare services. Telemedicine remotely links patients to specialty healthcare providers in an effort to increase accessibility to healthcare systems for isolated and rural populations [1] [2] [3] [4] [5] [6] [7] . As many infectious diseases physicians practice in or near academic centers, telemedicine has the potential to provide much-needed specialty infectious diseases care to patients outside these areas. Telemedicine has been described in the management of acute infectious diseases as well as chronic infections including hepatitis C virus (HCV), human immunodeficiency virus (HIV), and tuberculosis [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] . With respect to infectious diseases, telemedicine has been used to link patients directly to specialty healthcare providers, to facilitate consultations between primary care providers and specialists, and to deliver continuing medical education (CME) [8, 9, 13, 14] . Many studies cite common reasons in support of implementing telemedicine programs: telemedicine promises increased access, increased uptake of treatment, and potential costeffectiveness [1-9, 13-15, 17, 18] .
We summarize the usage of telemedicine technologies in the management of acute and chronic infectious diseases and consider the potential advantages and disadvantages of incorporating telemedicine into infectious diseases practices (Table 1) . We also identify areas within infectious diseases that telemedicine technologies have yet to engage but could prove beneficial.
METHODS
The authors searched the following databases for randomized trials: PubMed, Cumulative Index to Nursing and Allied Health Literature, and Embase. Reference lists of included articles were also reviewed. Key search terms included telemedicine plus infectious diseases, HIV, HBV, HCV, tuberculosis, chronic diseases, and cost-effectiveness. In this review, we included publications that specifically evaluated telemedicine or related technologies and infectious diseases. Publication evaluation and information synthesis were completed jointly by each author. [19] • Open-label, 2-arm, prospective, randomized study • Internet-based care model covering the entire management of chronic HIVinfected patients (Virtual Hospital) 42 Virtual Hospital (arm 1) 41 standard care (arm 2)
• Clinical parameters (P = .21), compliance levels (P = .58), and psychological measures similar between arms • Virtual Hospital is a cost-effective alternative to in-clinic visits • Constitutes a feasible, fairly satisfactory, safe, and low-cost tool for the clinical care of stable HIV-infected patients • Has no negative effect on HIV clinical parameters and health services utilization • TM is an appropriate support service for HIV management
• Small sample size • Single center HIV Young et al [7] • Retrospective cohort study.
• Compare efficacy of HIV specialty management via TM in a large prison population vs on-site management by a correctional physician without specialty training 1201 Pre-TM DB = 514 TM DB = 687
• TM specialty care resulted in a greater proportion of patients with virologic suppression (P < .001), lower community viral load (geometric mean of viral load of each subject) (P < .001), and better patient adherence (P < .001) compared with nonexpert care
• Observational, retrospective study design, potential overlap of study subjects in each group, exclusion of inmates incarcerated for short periods of time HCV Arora et al [9] • Prospective cohort study • Equivalent SVR (TM = 55% vs FTF = 43%, P = .36) • TM group therapy completion was superior (TM = 78% vs FTF = 53%, P = .03), TM patients had more visits/ week (TM = 0.61 vs FTF = 0.07, P < .001), incidence of anemia was lower in TM group than FTF (TM = 25% vs FTF = 53%, P = .02) • TM can potentially close the gap of access to specialty care in remote areas without sacrificing patient care quality
• Study design, small sample size, number of TM sites Limited power to detect minute differences in the primary endpoint. Only 1 academic center was selected as a control. At time of publication, patient satisfaction data had not been collected HCV Rossaro et al [3] • Retrospective, single-site cohort study
103
• Tx naive = 65 (64%)
• Tx recommended = 19 (23%)
• Uncontrolled, retrospective, single-site cohort study • Single-center prospective cohort pilot study • Determine usefulness of videophone DOT as a supplement to community DOT (Toronto Public Health)
13
• VDOT is a patient-friendly and costeffective method of delivering DOT to carefully selected patients with tuberculosis • Compliance rates were similar for both community DOT and VDOT patients • VDOT visit time less than CDOT visit • Cons: less personal interaction, difficulty conducting a physical assessment
• Sample highly selected. Single center, small sample size. Letter to editor, no detailed methodology or results
Tuberculosis
Gennai et al [20] • Observational prospective cohort study • Describe patterns of solicited consultations provided by ID consultation hotline at a university affiliated, public, or private hospitals, and ambulatory medicine in Grenoble Tuberculosis = 89 of 3990 total
• High number of HIDC requests suggests hotline responds to a need of attending physicians • Provide rapid answers and replace certain formal consultations and hospitalizations • Questions raised on the quality of information exchanged, transfer of responsibility, and payment
• Could not identify whether several consultations were made for the same patient (analysis unit was the consultation) • Did not assess the quality of the recommendations given by specialist • Study conducted in a single university hospital Tuberculosis Wade et al [16] .
• Retrospective cohort study • Evaluate the clinical and costeffectiveness of a TM (videophone) service delivering direct observation, compared to an in-person drive-around service 128
• Home videophone could offer a means of supplying a high rate of direct observation • Did not improve the number of observations missed due to patient absence or refusal • Video service was cost-effective compared to a drive-around servicemay cost more than many tuberculosis services can afford
• Retrospective cohort design, effect of confounding factors unknown, different demographic characteristics between videophone and nonvideophone groups Community-acquired pneumonia Eron et al [21] • Case-control pilot study • Use of TM in the home to monitor moderately to severely ill patients with
16
• Cost effectiveness-pilot trial would have saved $135 000-$540 000 over 1 year • Patients returned to normal function sooner than hospitalized patients (P < .001) • TM group was more comfortable at home (P = .35), but would have felt safer in the hospital (P = .09)
• Charlson, Karnofsky, and severity of illness scores were similar between groups Community-acquired pneumonia dos Santos et al [22] .
• Single-center prospective cohort study • Patients spent fewer days hospitalized (P = .06) and fewer days receiving IV antibiotics (P = .05) than patients receiving in-person visits • TM consultation and subsequent care via ID specialist is equally as effective as in-person ID consultation in a rural population
• Study did not account for all elements of population variability between groups (comorbid conditions) • Small sample size Abbreviations: AV, audiovisual; CDOT, community direct observed treatment; CI, confidence interval; CL, confidence limits; DB, database; DOT, directly observed therapy; ECHO, Extension for Community Healthcare Outcomes; FTF, face-to-face; HCV, hepatitis C virus; HIDC, Hotline for Infectious Disease Consultation; HIV, human immunodeficiency virus; ID, infectious diseases; ITT, intent to treat; IV, intravenous; MD, physicians; NS, not significant; OR, odds ratio; peg-IFN, pegylated interferon; RBV, ribavirin; ST, standard lecturing; SSTI, skin and soft tissue infection; SVR, sustained virologic response; TM, telemedicine; Tx, treatment; UNM, University of New Mexico; URTI, upper respiratory tract infection; UTI, urinary tract infection; VC, videoconferencing; VDOT, videophone direct observed treatment.
Acute Infectious Diseases
Telemedicine technologies have been used to diagnose, treat, and follow up patients suffering from acute infectious diseases including community-acquired pneumonia, upper respiratory tract infections, skin and soft tissue infections, urinary tract infections, and bacterial endocarditis [18, [20] [21] [22] [23] . Although these conditions are entirely treatable with appropriate antimicrobial therapy, complications are not infrequent and often require consultation and/or follow-up with an infectious diseases specialist. A Brazilian study described improved antibiotic utilization by use of a telemedicine program. Two independent infectious diseases physicians reviewed antibiotic prescriptions written by hospitalists. They found that 55% of initial prescriptions were for an inappropriate choice of antibiotic [22] . Feedback was provided to the original prescribers via telemedicine, and in all cases the prescribing physicians accepted the advice of the reviewer and corrected the prescription [22] .
One rationale for following general infectious diseases patients via telemedicine is to decrease the length of time patients spend in hospital. When hospitalists were surveyed, they indicated a belief that >20% of hospital inpatients remained in hospital beyond the point at which they achieved clinical stability [18] . These prolonged hospital stays were due to concerns that premature discharge would be followed by subsequent clinician deterioration and adverse outcomes [18, 20, 21] . The potential for malpractice litigation due to suboptimal follow-up was also identified as a concern. Telemedicine can address issues related to timely follow-up after discharge, thereby averting costly, lengthy hospital stays [21] . A US study found that telemedicine patients spend fewer days in hospital and had fewer days of antibiotic therapy [21, 23] .
Telemedicine use in acute infection does have limitations. Use is predicated on the patient being in stable condition. Because critically ill patients require frequent monitoring and are at risk for deterioration requiring urgent medical interventions, unstable patients are poor candidates to be followed via telemedicine [18, 21] . In addition, discharged patients must be healthy enough to travel to their local telemedicine facility for follow-up assessment.
Chronic Infectious Diseases
The use of telemedicine to treat chronic medical conditions is increasing and has been described in the management of congestive heart failure, diabetes, and chronic obstructive pulmonary disease [24] [25] [26] [27] [28] [29] . Telemedicine technologies have also been used to manage patients with chronic infectious diseases including HIV, HCV, and HIV/HCV coinfection [1, 2, 4, 6, 7, 15, 19] . Although manageable as chronic medical conditions by nonspecialized healthcare providers, HIV and HCV care often requires the involvement of a specialist to supervise medication dosing and regimen selection, treatment initiation, and drug side effect management [1, 6, 15] . Assuming patient stability, infectious diseases specialist follow-up with HIV patients at intervals of 6-12 months has been demonstrated to enhance adherence, to optimize viral response to antiretroviral therapy and to be useful in the evaluation of routine blood work [19, 30, 31] . Similarly, HCV specialists can follow clinically stable patients not on antiviral therapy on a semiannual or yearly basis by utilizing telemedicine infrastructure.
There is also an important role for telemedicine in the delivery of antiviral therapy for HCV. Recent studies demonstrate that telemedicine and nontelemedicine HCV patients can achieve similar sustained virologic response rates when treated with pegylated interferon and ribavirin-based regimens [2, 4] . Furthermore, the rate of HCV therapy side effects was similar between groups. Of note, nontelemedicine patients were more likely to independently discontinue antiviral therapy due to an adverse drug reaction [4, 9] . It seems likely that the role for telemedicine technologies in HCV care delivery will increase as new, well-tolerated, simple-to-dose antiviral regimens become broadly available. However, there are currently no studies published that evaluate HCV treatment outcomes in recipients of interferon-free, direct-acting antiviral regimens receiving care via telemedicine programs. Among HIV patients on antiretroviral therapy, telemedicine and nontelemedicine patients had similar clinical responses to therapy, adherence to treatment, and quality-of-life scores as well as psychological and emotional states [19] . Another HIV telemedicine study conducted in a US prison cohort demonstrated that HIV patients on ART followed by a specialist via telemedicine were more likely to achieve virologic suppression and had greater CD4 cell recovery than patients who received their HIV care in person from a prison primary care physician [7] . Acknowledging the potential influence of selection and publication biases, the literature suggests that HIV and HCV telemedicine patients are able to achieve similar clinical outcomes to their nontelemedicine counterparts.
Tuberculosis, including active pulmonary, extrapulmonary, and latent infection, is another chronic infectious disease in which telemedicine may have an important role. Several public health pilot studies have evaluated treatment adherence of select, stable tuberculosis patients [10] [11] [12] 16] . Each study reported similar levels of treatment adherence in patients observed taking their tuberculosis therapy via telemedicine and those who were seen in person by a public health staff member [10] [11] [12] 16] . Thus far, tuberculosis telemedicine studies have only recruited sample patient cohorts and have focused only on directly observed therapy [10] [11] [12] 16] . Tuberculosis telemedicine programs could be expanded to involve initial patient evaluation (including clinical history, blood work, and chest radiographs), treatment initiation and management of treatment side effects. Following the example of HIV and HCV telemedicine programs, tuberculosis programs could also incorporate an element of CME to develop primary healthcare provider skills in comanaging patients with tuberculosis.
We were unable to identify any published studies detailing the use of telemedicine technologies to manage patients infected with hepatitis B virus (HBV). Like HCV, HBV is a chronic infectious disease affecting populations that are marginalized and face challenges to engaging traditional healthcare systems [32] . Unlike HCV, HBV is not curable. However, it can be suppressed using long-term antiviral therapy, thereby minimizing damage to liver parenchyma and preventing hepatocellular carcinoma. Because many clinically stable HBV patients can be followed by specialists on a semiannual or annual basis, they are ideal telemedicine candidates.
Advantages and Drawbacks of Telemedicine
As with other chronic diseases, patients with HIV, HCV, and tuberculosis receiving telemedicine care report feeling more satisfied with and more involved in their care [6, 7, 10-12, 16, 18] . Patients were pleased with the level of privacy during telemedicine appointments and the quality of the patient-healthcare professional relationship [6] . Telemedicine patients also claim that attending remote appointments through telemedicine saved them time, diminished the distance traveled, and reduced missed workdays [2, 4, 6, 7, 15, 18] . This is a clear benefit for patients. If they had to select again, the majority of telemedicine patients indicated that they would once more choose to have their appointments via telemedicine [15] . The risk for late appointment arrival and clinic visit cancellations are reduced. Beyond these advantages, the hazards involved with travel, particularly during periods of inclement weather conditions, are eliminated.
A primary advantage of telemedicine is increased accessibility to specialty care. This is a particular benefit for isolated populations including nursing home residents, individuals in prisons, and people living in rural communities [1] [2] [3] [4] [5] [6] [7] . A lack of specialty care for HIV-or HCV-infected individuals has been identified as a major obstacle to optimal care [15] . Rural HCV patients without access to specialty care are less likely to initiate antiviral treatment [4] . Increased access to specialty care through telemedicine allows many more patients to be promptly evaluated, triaged, and treated. In the case of acute infectious diseases, access to infectious disease specialists via telemedicine permits patients to be followed in the community instead of in the hospital.
Another allure of incorporating telemedicine into existing infectious diseases practices is the potential cost-effectiveness of telemedicine. Although many studies suggest that telemedicine is cost-effective, this claim remains debatable. Most telemedicine studies have not included a formal cost-effectiveness analysis [17] . Systematic analyses investigating the cost-effectiveness of telemedicine suggest that telemedicine may be no more costeffective than traditional clinic visits [33] . If this is the case, the patient would still benefit, but the specialist and/or the funding system would not. Furthermore, the cost-effectiveness varies tremendously from one region to another and from program to program. Therefore, cost-effectiveness cannot be generalized. More studies are needed to formally investigate the costeffectiveness of telemedicine programs [33, 34] .
The application of telemedicine for the care of incarcerated patients is particularly advantageous [7] . The expense involved with transportation with guards and the risk of escape is eliminated. The timeliness of assessment and initiation of treatment can be accelerated. In addition, the use of telemedicine is an excellent opportunity to provide infectious diseases and infection control education to the incarcerated patient and the correctional facility staff.
In addition to directly linking patients and specialist healthcare providers, telemedicine technologies have been used by primary healthcare providers to facilitate consults with specialists [8, 9, 13] . This enables delivery of competent care and comanagement of patients between primary care and specialty services [9] . For HCV, the link connecting primary care providers to hepatitis specialists has increased the numbers of HCV patients evaluated and treated [8, 9, 13] . Telemedicine has also been successfully used to deliver HCV-related CME to primary healthcare providers [8, 9, 13, 14] . In these US-based programs, infectious diseases experts and gastroenterologists prepare pedagogical CME slideshow presentations for primary healthcare providers on topics related to HCV and/or HIV and deliver them via telemedicine [8, 9, 13] . As part of the CME element, primary healthcare providers are responsible for presenting case reports on patients with particularly interesting or challenging cases of HIV or HCV [8, 9, 13] . One study focusing on HCV CME found that CME delivered via videoconference was as effective, if not more effective, than traditional CME [14] .
Key impediments to more widespread use of telemedicine in some jurisdictions include lack of reimbursement, tedious licensing and credentialing requirements, and concerns about security. This has created a scenario in which the potential benefits to the patient have not been realized due to poor physician adoption. In the United States, Medicare restrictions on telemedicine include requirements that the patient reside in a rural location and that the interview must be conducted in an approved healthcare facility (ie, not their home) [35] . In contrast, the Ontario Telemedicine Network has been proactive in facilitating physician access without arduous regulation or restriction [36] ; this physician service is also reimbursed by the Ontario provincial government. Other technologies, including Skype and FaceTime, could eliminate the need for patient travel to a healthcare facility. This approach would mitigate infection control concerns for patients with transmissible infections and protect them from hospital-acquired infections. Security breaches must be protected against. However, there are security risks irrespective of how and where healthcare is provided and does not justify failure to provide access to the benefits of telemedicine-based medical services to those in need.
A key disadvantage with telemedicine-based care over traditional in-clinic visits is the inability to perform full physical examination. Physical examinations through telemedicine are especially difficult if the picture quality of the telemedicine equipment is poor [12, 16] . Current telemedicine technologies do not allow for complete physical examinations to be performed remotely over the telemedicine platform. Of course, this is not an insurmountable obstacle. If a physical examination is required, telemedicine healthcare staff can either call patients into the clinic to perform the examination in person or rely on the findings of local healthcare professionals. Furthermore, the availability of peripheral devices such as teleauscultation devices can overcome this particular limitation [37] .
CONCLUSIONS
Telemedicine technologies are increasingly becoming incorporated into infectious diseases practices and have been described in the management of acute and chronic infectious diseases. Patients consistently report high levels of satisfaction with telemedicine-based care. Respiratory, urinary tract, skin and soft tissue, and other acute general infectious diseases have been treated using telemedicine. HIV, HCV, and tuberculosis patients have been successfully followed and treated with favorable clinical outcomes. Telemedicine studies evaluating HBV management and HCV treatments with interferon-free, all-oral antiviral therapies should be pursued. A key telemedicine advantage is increased access to healthcare for isolated populations. Telemedicine technology can also successfully deliver infectious diseases-related CME to primary healthcare professionals. Although many studies assert that telemedicine is cost-effective, systematic cost-analysis studies are few in number and conflicting in conclusions. Additional formal studies focused on this should be a priority.
Notes

